FI
ADMS

Fosun International’s Adamas Pharmaceuticals ADMS Stock Holding History

Fosun International’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-223,959
Closed -$1.33M – 316
2019
Q2 		$1.33M Hold
223,959
– – 0.09% 135
2019
Q1 		$1.61M Buy
223,959
+27,000
+14% +$243K 0.1% 118
2018
Q4 		$1.66M Buy
196,959
+136,959
+228% +$1.78M 0.1% 98
2018
Q3 		$1.15M Buy
+60,000
New +$1.41M 0.06% 125

Other funds holding ADMS

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fosun International's ADMS Position: Q3 2019 in Review

Fosun International sold out of Adamas Pharmaceuticals (ADMS) in Q3 2019, closing a stake of 223,959 shares — an estimated $1.33M sold.

Fosun International first reported a position in ADMS in Q3 2018 and held it in 4 quarters. The position peaked at $1.66M in Q4 2018. 87 funds tracked by Wall St. Rank hold ADMS as of Q3 2019.

  • Fosun International reported no remaining Adamas Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Fosun International sold 223,959 Adamas Pharmaceuticals shares in Q3 2019, an estimated $1.33M.
  • Fosun International first reported a position in Adamas Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Fosun International's Adamas Pharmaceuticals position peaked at $1.66M in Q4 2018.
  • 87 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2019.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.